OWC Pharmaceutical Research Corp. (OTCPK: OWCP)
Health Care · Pharmaceuticals · IL
$0.00
-90.00% today · 0.0% 1Y
OWC Pharmaceutical Research Corp. (OTCPK: OWCP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $497.00 and employs 9 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.28.
Tweenvest scores OWC Pharmaceutical Research Corp. across four factors: quality 27/100. Its strongest factor is quality.
OWCP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $497.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- -306.59
- 52-week high
- $0.28
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 497.50M
- Employees
- 9
- Next earnings
- —
About OWC Pharmaceutical Research Corp.
OWC Pharmaceutical Research Corp., which operates through its subsidiary One World Cannabis Ltd., primarily focuses on the research and development of cannabis-based medical products. The company is dedicated to developing cannabis-derived therapies for a variety of conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder (PTSD), chronic pain, and fibromyalgia. It is also innovating with a cannabis soluble tablet delivery system. Furthermore, OWC Pharmaceutical extends its expertise by providing consulting services to both private companies and governmental agencies on international medical cannabis protocols and regulatory frameworks. Founded in 2008 as Dynamic Applications Corp., the company adopted its current name, OWC Pharmaceutical Research Corp., in December 2014. Its headquarters are located in Ramat Gan, Israel.
- ISIN
- US67109N1081
- Founded
- 2008
- Listed since
- Sep 4, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.